Drug Trial Radar · NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
420
Planned (sponsor's estimate)
Start
May 19, 2021
Primary completion
Dec 29, 2028
Study completion Sep 22, 2030
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Mar 23, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of bleximenib in phase 1 Part 1 (Dose Escalation) and to determine the safety and tolerability at RP2D in Phase 1 Part 2 (Dose expansion). The purpose of the Phase 2 part of the study is to evaluate the efficacy of bleximenib at the RP2D.
Conditions
- Acute Leukemia
Interventions
BleximenibDrug
Bleximenib is administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: Number of Participants with Adverse Events (AEs) as a Measure of Safety and TolerabilityTime frame: Up to 4 years and 9 months
- Phase 1: Number of Participants with AEs by SeverityTime frame: Up to 4 years and 9 months
- Phase 1: Part 1: Percentage of Participants with Dose-Limiting Toxicity (DLT)Time frame: Up to 28 days Cycle 1
- Phase 2: Rate of Complete Remission or Complete Remission with Partial Hematologic Recovery (CR/CRh)Time frame: Up to 4 years and 9 months
Locations
102 sites in 13 countries. Site status is shown where the registry gives one.
City of Hope
Duarte, California · Recruiting
University of California Irvine Medical Center
Orange, California · Completed
University of California San Francisco
San Francisco, California · Recruiting
UCSF Benioff Children's Hospital
San Francisco, California · Recruiting
University of Chicago
Chicago, Illinois · Recruiting
St Francis Hospital & Health Centers Indiana Blood and Marrow Transplantation
Indianapolis, Indiana · Recruiting
Norton Cancer Institute
Louisville, Kentucky · Completed
Maine Health
South Portland, Maine · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Recruiting
Karmanos Cancer Institute
Detroit, Michigan · Completed
Start Midwest
Grand Rapids, Michigan · Recruiting
University of New Mexico
Albuquerque, New Mexico · Recruiting
Roswell Park Comprehensive Cancer Center
Buffalo, New York · Recruiting
NYU Langone Medical Center
New York, New York · Recruiting
Montefiore Medical Center
The Bronx, New York · Recruiting
Oregon Health And Science University
Portland, Oregon · Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania · Completed
University of Tennessee Medical Center
Knoxville, Tennessee · Recruiting
Baylor University Medical Center
Dallas, Texas · Recruiting
Houston Methodist Hospital
Houston, Texas · Recruiting
MD Anderson
Houston, Texas · Recruiting
San Antonio Methodist TX Transplant Physicians Group
San Antonio, Texas · Recruiting
Virginia Commonwealth University
Richmond, Virginia · Recruiting
Swedish Cancer Institute
Seattle, Washington · Recruiting
Medical College of WI at Froedtert
Milwaukee, Wisconsin · Recruiting
Monash Medical Centre
Clayton, Australia · Recruiting
Royal Perth Hospital
Perth, Australia · Recruiting
Gold Coast University Hospital
Southport, Australia · Recruiting
Ghent University Hospital
Ghent, Belgium · Recruiting
IDOR - Regional Brasilia
Brasília, Brazil · Recruiting
Liga Norte Riograndense Contra O Cancer
Natal, Brazil · Recruiting
Ministerio da Saude Instituto Nacional do Cancer
Rio de Janeiro, Brazil · Recruiting
Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
São Paulo, Brazil · Recruiting
IDOR - Regional Sao Paulo
São Paulo, Brazil · Recruiting
Fundacao Antonio Prudente A C Camargo Cancer Center
São Paulo, Brazil · Recruiting
Vancouver Coastal Health
Vancouver, British Columbia, Canada · Recruiting
Princess Margaret Cancer Centre University Health Network
Toronto, Ontario, Canada · Recruiting
Hopital Maisonneuve Rosemont
Montreal, Quebec, Canada · Recruiting
Peking University First Hospital
Beijing, China · Recruiting
Showing 40 of 102 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.